Phase I study of safety, pharmacokinetics, and efficacy of TSU-68 plus S-1 combination in patients with advanced hepatocellular carcinoma.
Masafumi Ikeda
Honoraria - Taiho Pharmaceutical; Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical; Taiho Pharmaceutical
Shuichiro Shiina
No relevant relationships to disclose
Kohei Nakachi
No relevant relationships to disclose
Shuichi Mitsunaga
No relevant relationships to disclose
Satoshi Shimizu
No relevant relationships to disclose
Yasushi Kojima
No relevant relationships to disclose
Hideki Ueno
Honoraria - Taiho Pharmaceutical; Taiho Pharmaceutical
Chigusa Morizane
No relevant relationships to disclose
Shunsuke Kondo
No relevant relationships to disclose
Yasunari Sakamoto
No relevant relationships to disclose
Ryosuke Tateishi
No relevant relationships to disclose
Yoshinari Asaoka
No relevant relationships to disclose
Kazuhiko Koike
No relevant relationships to disclose
Hitoshi Arioka
Honoraria - Taiho Pharmaceutical
Takuji Okusaka
Honoraria - Taiho Pharmaceutical; Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical; Taiho Pharmaceutical